News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SILVERNAIL LAUREN P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/19/2022 |
4
| SILVERNAIL LAUREN P (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 20,335 options to buy
@ $1.62, valued at
$32.9k
|
|
| 09/19/2022 |
3
| SILVERNAIL LAUREN P (Director) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 05/18/2022 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 16,189 shares
@ $13.9202, valued at
$225.4k
Sold 52,015 shares
@ $12.42, valued at
$646k
|
|
| 03/10/2022 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 10,192 shares
@ $9.7254, valued at
$99.1k
|
|
| 01/26/2022 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 53,571 shares
@ $0
Granted 77,640 options to buy
@ $5.46, valued at
$423.9k
|
|
| 08/12/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 2,699 shares
@ $7.46, valued at
$20.1k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 26,000 shares
@ $0
Granted 45,000 options to buy
@ $10.19, valued at
$458.6k
|
|
| 05/31/2019 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 2,612 shares
@ $13.5345, valued at
$35.4k
|
|
| 01/25/2019 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 45,000 options to buy
@ $16.19, valued at
$728.6k
|
|
| 05/31/2018 |
4
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 200,000 options to buy
@ $22.44, valued at
$4.5M
|
|
| 05/31/2018 |
3
| SILVERNAIL LAUREN P (See Remarks) has filed a Form 3 on Evolus, Inc. |
| 05/24/2018 |
4
| SILVERNAIL LAUREN P (CFO & CBO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 2,874 shares
@ $30.2451, valued at
$86.9k
|
|
| 03/23/2018 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 3,431 shares
@ $30.8478, valued at
$105.8k
|
|
| 03/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2018 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $31.5, valued at
$315k
Sold 10,000 shares
@ $32.5, valued at
$325k
Exercised 10,000 options to buy
@ $8.7, valued at
$87k
Exercised 10,000 options to buy
@ $8.7, valued at
$87k
|
|
| 02/16/2018 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,136 shares
@ $31.75, valued at
$36.1k
|
|
| 02/09/2018 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 8,125 shares
@ $0
Granted 48,750 options to buy
@ $29.15, valued at
$1.4M
|
|
| 01/30/2018 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 990 shares
@ $33.5, valued at
$33.2k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Exercised 17,506 options to buy
@ $8.7, valued at
$152.3k
|
|
| 11/09/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $26.8267, valued at
$268.3k
Exercised 10,000 options to buy
@ $8.7, valued at
$87k
|
|
| 10/16/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 11,164 shares
@ $26.6714, valued at
$297.8k
|
|
| 07/05/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Acquired 604 shares
@ $18.3175, valued at
$11.1k
|
|
| 05/31/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Exercised 23,000 options to buy
@ $8.7, valued at
$200.1k
|
|
| 05/24/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 1,793 shares
@ $20.1964, valued at
$36.2k
|
|
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2017 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc. |
| 07/05/2016 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Acquired 749 shares
@ $11.56, valued at
$8.7k
|
|
| 05/23/2016 |
4
| SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,753 shares
@ $17.11, valued at
$30k
|
|
| 02/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|